View of REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD)

Return to Article Details REMTERNETUG: AN INVESTIGATIONAL MONOCLONAL ANTIBODY AGAINST Β-AMYLOID FOR THE TREATMENT OF ALZHEIMER’S DISEASE (AD) Download Download PDF